SMTL ID : 6yqp.1

Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW22

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.25 Å

Oligo State

monomer

Ligands

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 5 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, N.94 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62, A:N.94 EDO.2: 7 residues within 4Å: Chain A: R.17, Q.18, L.22, Q.23, L.26, L.73, N.76 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.76 Water bridges: A:T.19, A:N.76 EDO.3: 4 residues within 4Å: Chain A: T.32, K.35, L.115, K.119 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.35, A:K.119, A:K.119

1 x P8N: (~{E})-3-[4-[[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6 ),4,7,10,12-pentaen-9-yl]ethanoylamino]methyl]phenyl]-~{N}-oxidanyl-prop-2-enamide(Non-covalent)

P8N.4: 10 residues within 4Å: Chain A: W.40, P.41, F.42, V.46, L.51, L.53, N.99, D.104, I.105, M.108 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.40, A:W.40, A:P.41, A:F.42, A:V.46, A:L.51, A:L.51, A:L.53, A:D.104, A:I.105, A:I.105 Hydrogen bonds: A:N.99, A:N.99, A:D.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, X. et al., Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. Int.J.Cancer (2020)

Release Date

2020-05-27

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence